• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测心血管疾病风险的脂蛋白谱的新兴生物标志物和决定因素:对精准营养的启示。

Emerging Biomarkers and Determinants of Lipoprotein Profiles to Predict CVD Risk: Implications for Precision Nutrition.

作者信息

Andersen Catherine J, Fernandez Maria Luz

机构信息

Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA.

School of Nutrition and Wellness, University of Arizona, Tucson, AZ 85712, USA.

出版信息

Nutrients. 2024 Dec 27;17(1):42. doi: 10.3390/nu17010042.

DOI:10.3390/nu17010042
PMID:39796476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11722654/
Abstract

Biomarkers constitute a valuable tool to diagnose both the incidence and the prevalence of chronic diseases and may help to inform the design and effectiveness of precision nutrition interventions. Cardiovascular disease (CVD) continues to be the foremost cause of death all over the world. While the reasons that lead to increased risk for CVD are multifactorial, dyslipidemias, plasma concentrations of specific lipoproteins, and dynamic measures of lipoprotein function are strong biomarkers to predict and document coronary heart disease incidence. The aim of this review is to provide a comprehensive evaluation of the biomarkers and emerging approaches that can be utilized to characterize lipoprotein profiles as predictive tools for assessing CVD risk, including the assessment of traditional clinical lipid panels, measures of lipoprotein efflux capacity and inflammatory and antioxidant activity, and omics-based characterization of lipoprotein composition and regulators of lipoprotein metabolism. In addition, we discuss demographic, genetic, metagenomic, and lifestyle determinants of lipoprotein profiles-such as age, sex, gene variants and single-nucleotide polymorphisms, gut microbiome profiles, dietary patterns, physical inactivity, obesity status, smoking and alcohol intake, and stress-which are likely to be essential factors to explain interindividual responses to precision nutrition recommendations to mitigate CVD risk.

摘要

生物标志物是诊断慢性病发病率和患病率的宝贵工具,可能有助于为精准营养干预措施的设计和有效性提供信息。心血管疾病(CVD)仍然是全球首要的死亡原因。虽然导致心血管疾病风险增加的原因是多方面的,但血脂异常、特定脂蛋白的血浆浓度以及脂蛋白功能的动态指标是预测和记录冠心病发病率的有力生物标志物。本综述的目的是全面评估可用于将脂蛋白谱表征为评估心血管疾病风险的预测工具的生物标志物和新兴方法,包括传统临床血脂指标的评估、脂蛋白流出能力以及炎症和抗氧化活性的测定,以及基于组学的脂蛋白组成和脂蛋白代谢调节因子的表征。此外,我们还讨论了脂蛋白谱的人口统计学、遗传学、宏基因组学和生活方式决定因素,如年龄、性别、基因变异和单核苷酸多态性、肠道微生物群谱、饮食模式、身体活动不足、肥胖状况、吸烟和饮酒以及压力,这些可能是解释个体对精准营养建议减轻心血管疾病风险反应差异的关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2839/11722654/af3871cba7c5/nutrients-17-00042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2839/11722654/af3871cba7c5/nutrients-17-00042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2839/11722654/af3871cba7c5/nutrients-17-00042-g001.jpg

相似文献

1
Emerging Biomarkers and Determinants of Lipoprotein Profiles to Predict CVD Risk: Implications for Precision Nutrition.用于预测心血管疾病风险的脂蛋白谱的新兴生物标志物和决定因素:对精准营养的启示。
Nutrients. 2024 Dec 27;17(1):42. doi: 10.3390/nu17010042.
2
Precision Nutrition and Cardiovascular Disease Risk Reduction: the Promise of High-Density Lipoproteins.精准营养与心血管疾病风险降低:高密度脂蛋白的前景。
Curr Atheroscler Rep. 2023 Oct;25(10):663-677. doi: 10.1007/s11883-023-01148-5. Epub 2023 Sep 13.
3
Precision Nutrition for Management of Cardiovascular Disease Risk during Menopause.精准营养在绝经后心血管疾病风险管理中的应用。
Lifestyle Genom. 2024;17(1):93-101. doi: 10.1159/000540337. Epub 2024 Jul 24.
4
Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.富含甘油三酯的脂蛋白作为心血管疾病的一个致病因素。
Vasc Health Risk Manag. 2016 May 6;12:171-83. doi: 10.2147/VHRM.S104369. eCollection 2016.
5
Lipids, Apolipoproteins, and Inflammatory Biomarkers of Cardiovascular Risk: What Have We Learned?脂类、载脂蛋白与心血管风险的炎症生物标志物:我们有何新发现?
Clin Pharmacol Ther. 2018 Aug;104(2):244-256. doi: 10.1002/cpt.1114. Epub 2018 Jun 27.
6
LDL subfractions are associated with incident cardiovascular disease in the Malmö Prevention Project Study.LDL 亚组份与马尔默预防项目研究中的心血管疾病事件相关。
Atherosclerosis. 2017 Aug;263:287-292. doi: 10.1016/j.atherosclerosis.2017.07.003. Epub 2017 Jul 5.
7
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.残余心血管风险的分子来源、临床信号及创新解决方案:与亚临床疾病、治疗不足及依从性差的关系:新证据对优化心血管疾病患者预后的影响
Vasc Health Risk Manag. 2013;9:617-70. doi: 10.2147/VHRM.S37119. Epub 2013 Oct 21.
8
Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine.动脉粥样硬化性心血管疾病的生化风险因素:从狭义且具争议的方法到整体方法和精准医学。
Expert Rev Cardiovasc Ther. 2021 Dec;19(12):1085-1096. doi: 10.1080/14779072.2021.2022475. Epub 2022 Jan 3.
9
Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy.脂质代谢与降脂治疗的新靶点
Can J Cardiol. 2017 Jul;33(7):872-882. doi: 10.1016/j.cjca.2016.12.019. Epub 2017 Jan 16.
10
The relationships between biological novel biomarkers Lp-PLA and CTRP-3 and CVD in patients with type 2 diabetes mellitus.生物新型标志物 Lp-PLA2 和 CTRP-3 与 2 型糖尿病患者 CVD 的关系。
J Diabetes. 2024 Jul;16(7):e13574. doi: 10.1111/1753-0407.13574.

引用本文的文献

1
Effects of a competitive season on the plasma lipid profile of soccer players.赛季对足球运动员血浆脂质谱的影响。
Physiol Rep. 2025 May;13(10):e70382. doi: 10.14814/phy2.70382.
2
Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk.血脂异常和心血管代谢风险管理中的营养与生活方式干预
Nutrients. 2025 Feb 23;17(5):776. doi: 10.3390/nu17050776.

本文引用的文献

1
Clinical Relevance of Nuclear Magnetic Resonance LipoProfile.核磁共振脂质谱的临床相关性
Front Nucl Med. 2022 Jul 13;2:960522. doi: 10.3389/fnume.2022.960522. eCollection 2022.
2
Trimethylamine N-Oxide as a Potential Biomarker for Cardiovascular Disease: Its Association with Dietary Sources of Trimethylamine N-Oxide and Microbiota.氧化三甲胺作为心血管疾病的潜在生物标志物:其与氧化三甲胺饮食来源及微生物群的关联
Eurasian J Med. 2023 Oct;55(1):S21-S26. doi: 10.5152/eurasianjmed.2023.23070.
3
Navigating Challenges and Opportunities in Multi-Omics Integration for Personalized Healthcare.
个性化医疗中多组学整合的挑战与机遇探索
Biomedicines. 2024 Jul 5;12(7):1496. doi: 10.3390/biomedicines12071496.
4
Observational studies: practical tips for avoiding common statistical pitfalls.观察性研究:避免常见统计陷阱的实用技巧。
Lancet Reg Health Southeast Asia. 2024 May 9;25:100415. doi: 10.1016/j.lansea.2024.100415. eCollection 2024 Jun.
5
Plasma proteome association with coronary heart disease and carotid intima media thickness: results from the KORA F4 study.血浆蛋白质组与冠心病及颈动脉内膜中层厚度的关系:来自 KORA F4 研究的结果。
Cardiovasc Diabetol. 2024 May 29;23(1):181. doi: 10.1186/s12933-024-02274-3.
6
The Interplay of Microbiome Dysbiosis and Cardiovascular Disease.微生物群失调与心血管疾病的相互作用
Cardiol Rev. 2024 Apr 26. doi: 10.1097/CRD.0000000000000701.
7
Dietary Adherence Is Associated with Perceived Stress, Anhedonia, and Food Insecurity Independent of Adiposity.饮食依从性与感知压力、快感缺失和与肥胖无关的食物不安全感有关。
Nutrients. 2024 Feb 14;16(4):526. doi: 10.3390/nu16040526.
8
Prevalence of dyslipidemia and associated factors in sedentary occupational population from Shanghai: a cross-sectional study.上海久坐职业人群血脂异常患病率及其相关因素:一项横断面研究。
Arch Public Health. 2024 Feb 8;82(1):21. doi: 10.1186/s13690-024-01245-0.
9
Association between dietary patterns and cardiovascular diseases: A review.饮食模式与心血管疾病之间的关联:综述
Curr Probl Cardiol. 2024 Mar;49(3):102412. doi: 10.1016/j.cpcardiol.2024.102412. Epub 2024 Jan 24.
10
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据:美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.